PropertyValue
?:abstract
  • COVID-19 is a zoonotic illness caused by a new strain of coronavirus and has recently been declared a pandemic by the World Health Organization, with an estimated fatality rate of 1% to 2%. Early identification and isolation of patients in the preliminary infective stage has been a mainstay of most governmental strategies in order to limit transmission. Four otherwise healthy patients presented to a specialist open access Ear, Nose & Throat Clinic in central London with acute total or subtotal loss of their sense of smell in a single one-week period, coinciding with rapid escalation of COVID-19 infection in the indigenous population. The diagnosis was confirmed by the validated University of Pennsylvania Smell Identification Test (UPSIT) in 3. Endoscopic examination and magnetic resonance imaging (2 cases) excluded a range of alternative potential pathological conditions. Covid-19 antibody testing carried out 6 to 8 weeks after the onset of nasal symptoms showed positive immunoglobulin G antibodies in 3 of the 4 patients. Acute severe anosmia is therefore almost certainly an unusual presenting local nasal feature of a COVID-19 viral infection. All 4 patients achieved significant partial olfactory recovery by one week after treatment with subjective ratings of 40% to 85% of normal (mean 60%) and complete olfaction recovery after 2 to 3 weeks in all 4 patients. The significance, possible pathogenesis, and public health implications are highlighted and discussed.
?:creator
?:doi
  • 10.1177/0145561320940119
?:doi
?:journal
  • Ear_Nose_Throat_J
?:license
  • cc-by-nc
?:pdf_json_files
  • document_parses/pdf_json/eddab369a24c2b1185dc22b16584beb86f1abe30.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7412078.xml.json
?:pmcid
?:pmid
?:pmid
  • 32757995.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Acute Olfactory Dysfunction—A Primary Presentation of COVID-19 Infection
?:type
?:year
  • 2020-08-06

Metadata

Anon_0  
expand all